Latest BioFortis Inc. Stories
COLUMBIA, Md., April 13, 2011 /PRNewswire/ -- BioFortis, Inc.
COLUMBIA, Md., April 6, 2011 /PRNewswire/ -- The Catalysis Foundation for Health has selected the Labmatrix(TM) scientific database software system to manage its large-scale international tuberculosis (TB) diagnostic biomarker study that is funded by the Bill & Melinda Gates Foundation. The Catalysis Foundation for Health (CFH) is a non-profit organization dedicated to developing and delivering high value diagnostic tests for resource-poor settings.
COLUMBIA, Md., March 23, 2011 /PRNewswire/ -- Dr. Victor Levenson, a radiation oncologist at Rush University Medical Center, Chicago, and his scientific team have recently selected Labmatrix(TM) to manage their biobanking and biomarker research activities at this top-ranking U.S.
COLUMBIA, Md., Aug. 24 /PRNewswire/ -- Catholic Health Initiatives' (CHI) Institute for Research and Innovation's Center for Translational Research and BioFortis, Inc.
Biomedical Informatics Market Leader BioFortis wins another award for its Labmatrix(TM) platform being used by leading pharmaceutical and institutional clients worldwide for translational research, biomarker discovery, biobanking, and clinical research COLUMBIA, Md., March 5 /PRNewswire/ -- BioFortis, Inc., the leading provider of biomedical informatics solutions used by pharmaceutical and institutional clients, today announced it has won the 2009 Molecular Medicine Tri-Conference "Best...
- The act of sweetening by admixture of some saccharine substance.